Why this question comes up — the SSRI weight-gain context

If you are asking about ketamine and weight, there is a reasonable chance you came to this question through the back door of antidepressant side effects. SSRIs and SNRIs are the most commonly prescribed treatments for depression and anxiety in the United States, and weight gain is one of the most consistently reported reasons people try to come off them. The clinical literature backs up what many patients have lived through.

A 2010 meta-analysis by Serretti and Mandelli, published in the Journal of Clinical Psychiatry, pooled data across SSRI trials and found that several agents were associated with measurable weight gain over months of treatment. Paroxetine showed the most pronounced effect. Other SSRIs varied, with some appearing relatively weight-neutral in the short term and trending toward gain with longer use. The pattern was clear enough that prescribers now routinely flag this with patients before starting therapy.

So when patients arrive asking whether ketamine will do the same thing, the question is loaded with prior experience. The honest answer requires separating three different things: what ketamine itself does to body weight, what depression recovery does to appetite, and what the surrounding lifestyle looks like during a treatment series.

What we know about ketamine and appetite

The evidence base on ketamine and weight is smaller and less mature than the SSRI literature, but what exists is reassuring. A 2018 systematic review in Lancet Psychiatry by Short and colleagues evaluated ketamine’s adverse-effect profile across depression trials. Clinically significant weight change was not identified as a common adverse effect across the studies reviewed. Dissociation, transient blood-pressure elevation, and short-lived nausea dominated the side-effect tables. Weight did not.

That absence in the data is meaningful. SSRIs were tracked for years before the weight-gain signal solidified, but it eventually showed up clearly in pooled analyses. With ketamine, despite considerable research attention since the early 2000s, weight gain has not emerged as a recurring concern in published trials.

Ketamine is FDA-approved as an anesthetic; its use for depression, anxiety, PTSD, and chronic pain is off-label. That off-label framing matters here, because it means the studies reporting on weight come from psychiatric and pain populations rather than from any formal regulatory weight-tracking program. We are reading patterns out of side-effect tables, not pre-specified weight endpoints.

The mechanism by which ketamine works—NMDA receptor antagonism, downstream glutamate modulation, and a surge of synaptic plasticity in the prefrontal cortex and hippocampus—does not directly engage the metabolic pathways that drive SSRI-related weight gain. SSRIs influence histamine, serotonin 5-HT2C, and other receptors that regulate appetite and satiety. Ketamine’s primary targets sit in a different part of the pharmacology.

The depression-recovery effect on weight

Most weight changes that patients notice during a ketamine series are probably not caused by the medication directly. They are caused by depression lifting.

Major depression distorts appetite in two opposite directions. Some people lose interest in food entirely, eat less than they need, and lose weight that did not need to come off. Others reach for food as a coping behavior, particularly carbohydrate-heavy comfort food in the evenings, and gain weight that becomes its own source of distress. When depression starts to lift, both of these patterns can shift toward something more normal.

Patients who under-ate may notice meals start to taste like food again. Hunger cues that had gone quiet come back. Cooking, grocery shopping, and sitting down to eat with other people stop feeling like obstacles. People in this group sometimes regain a few pounds, and that regain is usually a sign of recovery, not a side effect to worry about.

Patients who comfort-ate may notice the opposite. The compulsive evening snacking eases. Cravings reduce. The emotional pull toward food in the absence of hunger gets quieter. People in this group sometimes lose a small amount of weight, and that loss is also a downstream effect of recovery rather than a direct ketamine effect.

This pattern is consistent with what we see clinically and with how depression itself is described in the diagnostic criteria. Either appetite increase or appetite decrease can be a feature of major depressive disorder; recovery moves the dial back toward baseline in whichever direction the patient was off.

Why we don't market ketamine as a weight-loss tool

This is the part of the conversation we want to be explicit about. Ketamine is not a weight-loss tool. We will not describe it that way, recommend it for that purpose, or suggest that weight loss is a reasonable goal of a treatment series.

The reasons are clinical, ethical, and practical.

Clinically, the weight effects we see are small, inconsistent, and downstream of mood improvement. They are not reliable enough to justify treatment, and the mechanism is not metabolic. There is no evidence that ketamine alters resting metabolic rate, fat oxidation, insulin sensitivity, or any of the pathways that genuine weight-loss interventions act on.

Ethically, framing a psychiatric treatment as a weight-loss intervention pushes patients to evaluate it on the wrong outcomes. If you go in hoping to lose weight and your mood improves but the scale does not move, you may walk away feeling the treatment failed when it actually did exactly what it is designed to do. We would rather set the right expectation up front.

Practically, ketamine is an off-label use with real costs and real screening requirements. Sessions at Music City Ketamine are $475 each. That is a meaningful financial commitment for an evidence-based treatment of treatment-resistant depression, anxiety, PTSD, and certain chronic pain conditions. It is not a reasonable spend for chasing a number on the scale.

The eating-disorder population — why we're extra careful

Patients with a history of anorexia, bulimia, binge-eating disorder, or significant disordered eating require extra screening before we proceed. A 2020 case report by Calabrese in Frontiers in Psychiatry discussed ketamine in eating disorders and the careful clinical considerations around treating populations whose relationship with appetite and body image is itself a target of illness.

The interaction is complex. On one hand, ketamine’s effects on rumination and rigid thinking patterns may be relevant to the cognitive features of some eating disorders. On the other, the dissociative experience and any small appetite shift can be destabilizing for someone whose disorder is organized around control of eating.

For these reasons, we coordinate with the patient’s eating-disorder treatment team before considering ketamine, and we are transparent when we believe ketamine is not appropriate at a given stage of recovery. Our deeper discussion of this is in our ketamine and eating disorders article.

What patients commonly report across a series

In our clinical experience and consistent with the published literature, most patients moving through a six-infusion ketamine series describe the weight side of their experience in a few recognizable ways.

Patients coming off SSRIs often report a related but different pattern: as they taper their SSRI under their prescriber’s guidance and begin or continue ketamine, some of the SSRI-related weight gain begins to reverse. This is consistent with what we describe in our article on ketamine and SSRI discontinuation. Never stop or change your SSRI without talking to your prescribing provider.

Tracking metrics that matter more than the scale

If you are someone who has had a complicated history with the scale, we recommend tracking other outcomes during your series. These tend to be more responsive to treatment, more clinically meaningful, and emotionally easier to engage with.

Eating well during a ketamine series matters too, but for reasons related to comfort and infusion-day tolerability rather than weight management. Our article on what to eat before and after ketamine covers the practical side.

When to flag a major appetite or weight change

Most appetite shifts during a ketamine series are mild and benign. There are a few situations where you should mention what you are noticing to your prescribing clinician or to us.

None of these are common, but they are worth reporting. We hear about them in your check-ins. If you are not sure whether something rises to the level of worth mentioning, mention it. We would rather have the data and tell you it is fine than miss something that mattered. For broader misconceptions about what ketamine does and does not do, our ketamine myths article addresses several of the most common.